Science can save industry tens of millions of dollars by preventing pollution and directing resources to areas that need it most, according to CSIRO.

Melbourne’s loss was Sydney’s gain today, when drug re-engineering company Eiffel Technologies (ASX:EIF) announced it would be upping stakes and moving its head office to Sydney’s biotechnology neighbourhood of North Ryde, adjoining its new semi-commercial production facility. [ + ]

In future, the tooth fairy may leave children something more than a silver coin in a glass of water, in exchange for their lost milk teeth. Researchers at the Hanson Institute in Adelaide believe pluripotent stem cells from those deciduous teeth could help sustain their owners' dental, skeletal, neural and cardiovascular health well into the autumn of their lives. [ + ]

Both public and private equity is out there for quality biotechnology ventures, say venture capitalists, and new initiatives and funds will only increase that. [ + ]

SciVentures Investments and Griffith University have teamed up to provide AUD$1.3 million of pre-seed funding to two Griffith University start-ups. [ + ]

Two Sydney cancer patients have made medical history this week as the first individuals to be diagnosed with cancer induced by spontaneous silencing of an otherwise normal tumour-suppressor gene. [ + ]

Melbourne biotech Norwood Abbey (ASX:NAL) is to sponsor a Monash Institute of Reproduction and Development group dedicated to research into the conservation and preservation of Australian animals. [ + ]

Adelaide biotech GroPep (ASX:GRO) has yanked its potential topical treatment for chronic venous ulcers after inconclusive results from a Phase II clinical trial. [ + ]

Biosignal (ASX:BOS) listed today on the Australian Stock Exchange, with shares leaping to AUD$0.38, a premium of almost 100 per cent on its $0.20 issue price. [ + ]

A state-of-the-art cellular neurophysiology laboratory was opened today at the University of Melbourne for the National Neuroscience Facility (NNF). [ + ]

Brisbane-based GeneTraks has received a $1 million R&D Start grant from the Commonwealth government for its AUD$2.6 million equine diagnostics development project. [ + ]

Phosphagenics (ASX:POH) -– formerly Vital Capital -– has announced the successful completion of animal studies for its transdermal delivery system for morphine. [ + ]

A company formed as part of the Victorian Biotechnology Entrepreneur Program, a pilot program of Young Achievers Australia and the Victorian State Government, has returned a whopping 900 per cent to its shareholders, through the sale of its products to a scientific supplies company. [ + ]

The wallaby genome project is poised to go ahead thanks to a last minute injection of $3 million into the project by the Victorian State Government. [ + ]

Norwood Abbey's UK subsidiary Norwood Immunology has revealed its plans to float on the London Stock Exchange's Alternative Investment Market (AIM) in May. [ + ]